Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

RAGE anticorps (N-Term)

L’anticorps anti-RAGE Polyclonal Lapin est utilisé pour la détection de RAGE dans des échantillons de Humain, Souris, Rat, Boeuf (Vache), Cobaye, Lapin, Chien, Cheval et Porc. Il a été validé pour WB.
N° du produit ABIN2776831
534,11 €
Plus frais de livraison 40,00 € et TVA
Destination: France
Envoi sous 6 à 9 jours ouvrables

Aperçu rapide pour RAGE anticorps (N-Term) (ABIN2776831)

Antigène

Voir toutes RAGE (AGER) Anticorps
RAGE (AGER) (Advanced Glycosylation End Product-Specific Receptor (AGER))

Reactivité

  • 187
  • 117
  • 106
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Humain, Souris, Rat, Boeuf (Vache), Cobaye, Lapin, Chien, Cheval, Porc

Hôte

  • 193
  • 24
  • 4
  • 3
  • 3
  • 2
Lapin

Clonalité

  • 188
  • 40
  • 1
Polyclonal

Conjugué

  • 92
  • 15
  • 14
  • 13
  • 12
  • 10
  • 8
  • 5
  • 5
  • 5
  • 5
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Cet anticorp RAGE est non-conjugé

Application

  • 145
  • 81
  • 76
  • 74
  • 29
  • 28
  • 20
  • 13
  • 9
  • 9
  • 7
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB)
  • Épitope

    • 39
    • 16
    • 16
    • 14
    • 13
    • 12
    • 12
    • 9
    • 9
    • 8
    • 7
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    N-Term

    Fonction

    AGER Antibody - N-terminal region

    Séquence

    FLPAVGIQDE GIFRCQAMNR NGKETKSNYR VRVYQIPGKP EIVDSASELT

    Specificité

    The immunizing peptide sequence is 100 % homologous to all four isoforms of AGER.

    Homologie

    Cow: 100%, Dog: 92%, Guinea Pig: 86%, Horse: 93%, Human: 100%, Mouse: 100%, Pig: 93%, Rabbit: 100%, Rat: 100%

    Attributs du produit

    This is a rabbit polyclonal antibody against AGER. It was validated on Western Blot using a cell lysate as a positive control.

    Purification

    Affinity Purified

    Immunogène

    The immunogen is a synthetic peptide directed towards the N terminal region of human AGER
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Commentaires

    We also sell a specific blocking peptide that can be used in combination with this antibody. You can find the blocking peptide under AAP41464-100UG

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    0.5 mg/mL

    Buffer

    Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Conseil sur la manipulation

    prevent freeze-thaw cycles

    Stock

    4 °C,-20 °C

    Stockage commentaire

    For short term use, store at 2-8C up to 1 week. For long term storage, store at -20 °C in small aliquots to prevent freeze-thaw cycles.
  • Antigène

    RAGE (AGER) (Advanced Glycosylation End Product-Specific Receptor (AGER))

    Autre désignation

    AGER

    Sujet

    Background Information: AGER mediates interactions of advanced glycosylation end products (AGE). These are nonenzymatically glycosylated proteins which accumulate in vascular tissue in aging and at an accelerated rate in diabetes. It is receptor for amyloid beta peptide.

    Gene Name: Advanced glycosylation end product-specific receptor

    Alternative Symbols: RAGE, sRAGE, SCARJ1

    Protein Name: Advanced glycosylation end product-specific receptor

    Poids moléculaire

    36kDa

    ID gène

    177

    NCBI Accession

    NP_751947

    UniProt

    Q15109

    Pathways

    Carbohydrate Homeostasis, Toll-Like Receptors Cascades, Smooth Muscle Cell Migration, S100 Proteins
Vous êtes ici:
Chat with us!